Vasoproliferative retinal tumors (VPRTs) are rare benign growths that arise from the retina, the light-sensitive tissue at the back of the eye. These tumors typically manifest as small, pinkish masses and can cause vision disturbances or even vision loss if they grow large enough to affect the central visual field. While VPRTs are not malignant, they can still pose significant challenges to vision and quality of life. Treatment options vary depending on the size and location of the tumor, ranging from observation to laser therapy or surgical intervention. Recent advancements in imaging techniques, such as optical coherence tomography (OCT) and fluorescein angiography, have improved our ability to diagnose and monitor VPRTs, leading to more personalized and effective treatment strategies. Ongoing research aims to further understand the underlying mechanisms driving VPRT development and to explore novel targeted therapies that can improve outcomes for affected individuals.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States